Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.30
+0.40 (1.54%)
At close: Feb 21, 2025, 4:00 PM
26.28
-0.02 (-0.08%)
After-hours: Feb 21, 2025, 7:59 PM EST
Pfizer Revenue
In the year 2024, Pfizer had annual revenue of $63.63B with 8.77% growth. Pfizer had revenue of $17.76B in the quarter ending December 31, 2024, with 24.66% growth.
Revenue (ttm)
$63.63B
Revenue Growth
+8.77%
P/S Ratio
2.34
Revenue / Employee
$723,034
Employees
88,000
Market Cap
149.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 63.63B | 5.13B | 8.77% |
| Dec 31, 2023 | 58.50B | -41.83B | -41.70% |
| Dec 31, 2022 | 100.33B | 19.04B | 23.43% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
PFE News
- 1 day ago - Pfizer: No More Growth - Still A Worthy Dividend Buy - Seeking Alpha
- 2 days ago - Pfizer says it will end global development of gene therapy Beqvez, Nikkei reports - Reuters
- 3 days ago - Dividend Harvesting Portfolio Week 207: $20,700 Allocated, $2,010.09 In Projected Dividends - Seeking Alpha
- 3 days ago - 10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers - Seeking Alpha
- 4 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields - Benzinga
- 4 days ago - Why Pfizer's Stock Price Isn't Reflecting Its True Value - Seeking Alpha
- 4 days ago - Pfizer Stock's Upside Got Bigger - Seeking Alpha
- 6 days ago - Pfizer: Danuglipron Could Tip The Scale In A Few Years, But For Now, Sell - Seeking Alpha